ARTICLE | Clinical News
Immune Network halts Phase I dapsone trial
March 26, 2001 8:00 AM UTC
Immune Network (IMMKF; CDNX:IMM) halted a Canadian Phase I trial of its dapsone anti-inflammatory sulfone small molecule that is in trials to treat Alzheimer's disease (see BioCentury, March 5). IMMK...